Endpoints News 生物医药· Lei Lei Wu·· 28 天前AI 评分58
Q&A: 布鲁克林-迈尔斯·霍奇女士谈自身免疫CAR-T疗法的安全挑战
Q&A: Bristol Myers' Lynelle Hoch on autoimmune CAR-T safety challenges
AI 导读
布鲁克林-迈尔斯的霍奇女士讨论了自身免疫CAR-T疗法面临的安全挑战,包括最近一名患者的死亡事件。
正文

Lynelle Hoch, president of Bristol Myers Squibb's cell therapy organization
October 23, 2026 02:36 PM EDT
Q&A: Bristol Myers’ Lynelle Hoch on autoimmune CAR-T safety challenges, new patient death
Bristol Myers Squibb is facing one problem after another with its autoimmune CAR-T therapy program. The company says it has figured out …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Think we're worth reading - tell Google.
Confirm Endpoints as a trusted biopharma news source
ENDPOINTS CAREERS
来源:Endpoints News 生物医药 · endpoints.news